The Value of CT and MRI in Evaluating the Efficacy of TACE Intervention in Patients With Unresectable Primary Liver Cancer
Objective To investigate the efficacy of CT and magnetic resonance imaging(MRI)in patients with unresectable primary liver cancer(HCC)after percutaneous hepatic arterial chemoembolization(TACE).It provides reference for the formulation of imaging evaluation criteria for the efficacy of TACE in the treatment of HCC.Methods A total of 166 patients with primary liver cancer who received TACE interventional therapy in Huizhou Municipal Central Hospital from January 2020 to January 2023 were selected as study subjects.3 months after treatment,all patients received CT and MRI scans,and digital subtraction angiography(DSA)was used as the gold standard.The application value of CT alone and CT combined with MRI in evaluating the postoperative efficacy of patients were analyzed.Results The maximum diameter range of the target lesions in the enrolled patients was 0.91-14.22 cm,with an average of(9.19±3.11)cm.After treatment,the reduction degree of the lesions was obvious,the total number of lesions was reduced from 196 to 172,and the maximum diameter range was 0.65-10.88 cm,with an average of(7.21±2.12)cm,lower than that before treatment(P<0.05),132 cases(79.52%)of disease control patients were detected.Disease control patients were detected in 112 cases(67.47%)by CT alone,126 cases(75.90%)by CT combined with MRI.The sensitivity and accuracy of CT combined with MRI were 92.42%and 91.57%,respectively,higher than 81.82%and 83.13%of CT alone(P<0.05),and there was no significant difference in specificity between the two methods(P>0.05).Conclusion CT combined with MRI is superior to CT alone in evaluating the efficacy of TACE intervention in patients with unresectable primary liver cancer,and its sensitivity and accuracy are higher.
万方数据
维普
